Hiroki Yokoyama

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Anterior Cruciate Ligament Reconstruction

Urinary Tract Infection

Glycemic Control

Top Venues

Journal of diabetes investigation

BMJ open diabetes research & care

This page only lists publications with an associated author ORCID identifier.

Publications

Ryotaro Bouchi, Takahiro Sugiyama, Atsushi Goto, Mitsuru Ohsugi, Narihito Yoshioka, Hideki Katagiri, Tomoya Mita, Yushi Hirota, Hiroshi Ikegami, Munehide Matsuhisa, Eiichi Araki, Hiroki Yokoyama, Masae Minami, Katsuya Yamazaki, Hideaki Jinnouchi, Hiroki Ikeda, Hitomi Fujii, Miyuki Nogawa, Masahiro Kaneshige, Kengo Miyo, Kohjiro Ueki
Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study. Journal of diabetes investigation (2023)
Ken-Ichi Tsuchida, Shinji Taneda, Isao Yokota, Kazufumi Okada, Yoshio Kurihara, Hiroki Yokoyama, Masahiro Iwamoto, Katsuya Yamazaki, Yasushi Ishigaki, Naoki Manda, Hiroshi Maegawa, null null
The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67). Journal of diabetes investigation 13 (11) (2022)
Hiroki Yokoyama, Shin-Ichi Araki, Katsuya Yamazaki, Koichi Kawai, Shin-Ichiro Shirabe, Mariko Oishi, Azuma Kanatsuka, Noriharu Yagi, Daijiro Kabata, Ayumi Shintani, Hiroshi Maegawa, null null
Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66). BMJ open diabetes research & care 10 (3) (2022)
Hiroki Yokoyama, Toshihiko Shiraiwa, Mitsuyoshi Takahara, Masahiro Iwamoto, Nobuichi Kuribayashi, Takuo Nomura, Minoru Yamada, Hirohito Sone, Shin-Ichi Araki
Applications of physical performance measures to routine diabetes care for frailty prevention concept: fundamental data with grip strength, gait speed, timed chair stand speed, standing balance, and knee extension strength. BMJ open diabetes research & care 8 (1) (2021)
Aika Miya, Akinobu Nakamura, Kyu Yong Cho, Shinichiro Kawata, Hiroshi Nomoto, So Nagai, Hajime Sugawara, Shinji Taneda, Kazuhisa Tsuchida, Kazuno Omori, Hiroki Yokoyama, Jun Takeuchi, Shin Aoki, Yoshio Kurihara, Tatsuya Atsumi, Hideaki Miyoshi
Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin. Journal of diabetes investigation 12 (8) (2021)
Noriharu Yagi, Ichiro Komiya, Keiko Arai, Mariko Oishi, Yoshihide Fukumoto, Shinichirou Shirabe, Hiroki Yokoyama, Katsuya Yamazaki, Hidekatsu Sugimoto, Hiroshi Maegawa, null null
Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61). Journal of diabetes investigation (2021)
Kyu Yong Cho, Hiroshi Nomoto, Akinobu Nakamura, Shinichiro Kawata, Hajime Sugawara, Jun Takeuchi, So Nagai, Kazuno Omori, Kazuhisa Tsuchida, Aika Miya, Ikumi Shigesawa, Kenichi Tsuchida, Shingo Yanagiya, Hiraku Kameda, Hiroki Yokoyama, Shinji Taneda, Yoshio Kurihara, Shin Aoki, Naoki Nishimoto, Tatsuya Atsumi, Hideaki Miyoshi
Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study. Journal of diabetes investigation 12 (8) (2021)
Megumi Oshima, Tadashi Toyama, Akinori Hara, Miho Shimizu, Shinji Kitajima, Yasunori Iwata, Norihiko Sakai, Kengo Furuichi, Masakazu Haneda, Tetsuya Babazono, Hiroki Yokoyama, Kunitoshi Iseki, Shin-Ichi Araki, Toshiharu Ninomiya, Shigeko Hara, Yoshiki Suzuki, Masayuki Iwano, Eiji Kusano, Tatsumi Moriya, Hiroaki Satoh, Hiroyuki Nakamura, Hirofumi Makino, Takashi Wada
Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes. BMJ open diabetes research & care 9 (1) (2021)
Hiroki Yokoyama, Shin-Ichi Araki, Koichi Kawai, Katsuya Yamazaki, Shin-Ichiro Shirabe, Hidekatsu Sugimoto, Masae Minami, Itsuko Miyazawa, Hiroshi Maegawa, null null
The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54). Diabetes care 43 (5) (2020)
Hiroki Yokoyama
Incidence of severe urinary tract infections not increased by initiating sodium-glucose cotransporter 2 inhibitors. Journal of diabetes investigation 11 (3) (2020)
Hiroki Yokoyama, Toshinaga Tsuji, Shinji Hayashi, Daijiro Kabata, Ayumi Shintani
Factors associated with diabetic polyneuropathy-related sensory symptoms and signs in patients with polyneuropathy: A cross-sectional Japanese study (JDDM 52) using a non-linear model. Journal of diabetes investigation 11 (2) (2019)
Hiroki Yokoyama, Ami Nagao, Sanae Watanabe, Jun Honjo
Incidence and risk of vaginal candidiasis associated with sodium-glucose cotransporter 2 inhibitors in real-world practice for women with type 2 diabetes. Journal of diabetes investigation 10 (2) (2018)